
PROCEPT BioRobotics Corporation: shareholders and insiders
Price
$23.54
November 16, 2026Market cap $1.3B
What Ploutos Investor adds for PROCEPT BioRobotics
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 17, 2025 to Nov 6, 2026, from their own Form 4 filings.
Bought on the market
$11M
2 people
Sold on the market
$716.7K
4 people
From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan31%
- The rest69%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 17, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $11M by 2 people·sold $716.7K by 4 people
- 2025: no buys, no sales
- 2026: bought $11M by 2 people, sold $716.7K by 4 people
- Nov 6, 2026Pooja SharmaChief Strat/Marketing OfficerKind
- Oct 2, 2026Michael MackDirectorKind
- Sep 9, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind
- Sep 9, 2026Barry L TemplinEVP, Chief Technology OfficerKind
- Sep 9, 2026Kevin WatersEVP, CFOKind
- Aug 13, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind
- Aug 13, 2026Barry L TemplinEVP, Chief Technology OfficerKind
- Aug 13, 2026Kevin WatersEVP, CFOKind
- Aug 13, 2026Pooja SharmaChief Strat/Marketing OfficerKind
- Aug 7, 2026Larry L WoodPresident, CEOKind
- Jun 9, 2026Antal Rohit DesaiDirectorKind
- Jun 9, 2026Amy M. DodrillDirectorKind
- Jun 9, 2026Mary GarrettDirectorKind
- Jun 9, 2026Taylor C. HarrisDirectorKind
- Jun 9, 2026Elisabeth Sandoval LittleDirectorKind
- Jun 9, 2026Frederic H MollDirectorKind
- Jun 9, 2026Thomas M PrescottDirectorKind
- Jun 9, 2026Dan PuckettDirectorKind
- Jun 8, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind
- Jun 8, 2026Kevin WatersEVP, CFOKind
- Jun 8, 2026Barry L TemplinEVP, Chief Technology OfficerKind
- Mar 19, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind10b5-1
- Mar 19, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind10b5-1
- Mar 17, 2026Kevin WatersEVP, CFOKind
- Mar 17, 2026Alaleh NouriEVP, CLO, CORP. SEC.Kind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Pooja SharmaChief Strat/Marketing Officer | 4,710 | $19.71 | $92.9K | Form 4 | |
| Oct 2, 2026 | Michael MackDirector | 7,727 | – | – | Form 4 | |
| Sep 9, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 297 | $20.95 | $6.2K | Form 4 | |
| Sep 9, 2026 | Barry L TemplinEVP, Chief Technology Officer | 373 | $20.95 | $7.8K | Form 4 | |
| Sep 9, 2026 | Kevin WatersEVP, CFO | 373 | $20.95 | $7.8K | Form 4 | |
| Aug 13, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 23.0K | – | – | Form 4 | |
| Aug 13, 2026 | Barry L TemplinEVP, Chief Technology Officer | 26.2K | – | – | Form 4 | |
| Aug 13, 2026 | Kevin WatersEVP, CFO | 29.5K | – | – | Form 4 | |
| Aug 13, 2026 | Pooja SharmaChief Strat/Marketing Officer | 23.6K | – | – | Form 4 | |
| Aug 7, 2026 | Larry L WoodPresident, CEO | 23.9K | $20.85 | $498.3K | Form 4 | |
| Jun 9, 2026 | Antal Rohit DesaiDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Amy M. DodrillDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Mary GarrettDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Taylor C. HarrisDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Elisabeth Sandoval LittleDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Frederic H MollDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Thomas M PrescottDirector | 3,315 | – | – | Form 4 | |
| Jun 9, 2026 | Dan PuckettDirector | 3,315 | – | – | Form 4 | |
| Jun 8, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 285 | $28.48 | $8.1K | Form 4 | |
| Jun 8, 2026 | Kevin WatersEVP, CFO | 357 | $28.48 | $10.2K | Form 4 | |
| Jun 8, 2026 | Barry L TemplinEVP, Chief Technology Officer | 358 | $28.48 | $10.2K | Form 4 | |
| Mar 19, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 10b5-1 | 2,332 | $26.15 | $61.0K | Form 4 |
| Mar 19, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 10b5-1 | 3,031 | $25.82 | $78.3K | Form 4 |
| Mar 17, 2026 | Kevin WatersEVP, CFO | 706 | $28.15 | $19.9K | Form 4 | |
| Mar 17, 2026 | Alaleh NouriEVP, CLO, CORP. SEC. | 304 | $28.15 | $8.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 10, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by PRCT's officers and directors from 2021 up to November 16, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class8.20%
- T. Rowe Price Investment Management, Inc.Share of class5.90%
- BNP Paribas Asset Management Holding S.A.Share of class5.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.20% | 4.65M | Jul 29, 2026 | 13G/A | |
| T. Rowe Price Investment Management, Inc. | 5.90% | 3.27M | Feb 17, 2026 | 13G | |
| BNP Paribas Asset Management Holding S.A. | 5.50% | 3.09M | Feb 11, 2026 | 13G |
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Millennium Mgmt (Englander)In the quarter-38%
- Citadel Advisors (Griffin)In the quarter
- AQR CapitalIn the quarter+45%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.05% | |
| Millennium Mgmt (Englander) | 624.3K | -38% | $14M | 0.01% |
| Citadel Advisors (Griffin) | 12.6K | $300.0K | 0.00% | |
| AQR Capital | 370.5K | +45% | $8.4M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 13.3% of its shares outstanding were held short, +1.0% since the report before.
- Shares held short
- 7.50M
- 13.3%
- Since the report before7.43M on Sep 30, 2026
- +1.0%
- 5.6
- 1.35M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 67%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 5.49M
- Nov 15, 2023: Shares held short 5.12M
- Nov 30, 2023: Shares held short 4.77M
- Dec 15, 2023: Shares held short 4.70M
- Dec 29, 2023: Shares held short 4.83M
- Jan 12, 2024: Shares held short 4.30M
- Jan 31, 2024: Shares held short 4.59M
- Feb 15, 2024: Shares held short 4.33M
- Feb 29, 2024: Shares held short 4.52M
- Mar 15, 2024: Shares held short 4.12M
- Mar 28, 2024: Shares held short 4.65M
- Apr 15, 2024: Shares held short 5.36M
- Apr 30, 2024: Shares held short 5.66M
- May 15, 2024: Shares held short 4.79M
- May 31, 2024: Shares held short 4.43M
- Jun 14, 2024: Shares held short 4.48M
- Jun 28, 2024: Shares held short 5.04M
- Jul 15, 2024: Shares held short 5.47M
- Jul 31, 2024: Shares held short 5.23M
- Aug 15, 2024: Shares held short 5.67M
- Aug 30, 2024: Shares held short 6.02M
- Sep 13, 2024: Shares held short 5.70M
- Sep 30, 2024: Shares held short 5.52M
- Oct 15, 2024: Shares held short 6.71M
- Oct 31, 2024: Shares held short 5.90M
- Nov 15, 2024: Shares held short 6.37M
- Nov 29, 2024: Shares held short 6.09M
- Dec 13, 2024: Shares held short 6.18M
- Dec 31, 2024: Shares held short 6.89M
- Jan 15, 2025: Shares held short 7.07M
- Jan 31, 2025: Shares held short 5.98M
- Feb 14, 2025: Shares held short 5.68M
- Feb 28, 2025: Shares held short 5.08M
- Mar 14, 2025: Shares held short 5.83M
- Mar 31, 2025: Shares held short 6.34M
- Apr 15, 2025: Shares held short 6.07M
- Apr 30, 2025: Shares held short 5.81M
- May 15, 2025: Shares held short 5.90M
- May 30, 2025: Shares held short 6.10M
- Jun 13, 2025: Shares held short 6.72M
- Jun 30, 2025: Shares held short 6.81M
- Jul 15, 2025: Shares held short 6.82M
- Jul 31, 2025: Shares held short 7.12M
- Aug 15, 2025: Shares held short 8.07M
- Aug 29, 2025: Shares held short 8.37M
- Sep 15, 2025: Shares held short 8.15M
- Sep 30, 2025: Shares held short 8.50M
- Oct 15, 2025: Shares held short 8.15M
- Oct 31, 2025: Shares held short 7.61M
- Nov 14, 2025: Shares held short 6.78M
- Nov 28, 2025: Shares held short 6.79M
- Dec 15, 2025: Shares held short 6.08M
- Dec 31, 2025: Shares held short 6.72M
- Jan 15, 2026: Shares held short 6.58M
- Jan 30, 2026: Shares held short 7.19M
- Feb 13, 2026: Shares held short 7.00M
- Feb 27, 2026: Shares held short 6.39M
- Mar 13, 2026: Shares held short 6.50M
- Mar 31, 2026: Shares held short 5.87M
- Apr 15, 2026: Shares held short 5.83M
- Apr 30, 2026: Shares held short 6.00M
- May 15, 2026: Shares held short 6.72M
- May 29, 2026: Shares held short 6.78M
- Jun 15, 2026: Shares held short 7.61M
- Jun 30, 2026: Shares held short 7.65M
- Jul 15, 2026: Shares held short 7.75M
- Jul 31, 2026: Shares held short 7.09M
- Aug 14, 2026: Shares held short 7.71M
- Aug 31, 2026: Shares held short 7.25M
- Sep 15, 2026: Shares held short 7.44M
- Sep 30, 2026: Shares held short 7.43M
- Oct 15, 2026: Shares held short 7.50M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading43.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 43.6% of the shares in the reported trades were short sales, against 50.5% in the 14 before.
- Last 14 sessionsOct 28, 2026 – Nov 16, 2026
- 43.6%
- The 14 beforeOct 8, 2026 – Oct 27, 2026
- 50.5%
- Change
- -6.9 pts
- Short sales a dayon average, of 508.6K shares
- 221.5K
- More than atof 3,668 US-listed companies, same days
- 29%
- Median of alleight in ten from 34.7% to 63.8%
- 50.3%
- Short sales
- Oct 8, 2026: Short sales 47.3%
- Oct 9, 2026: Short sales 49.5%
- Oct 12, 2026: Short sales 58.9%
- Oct 13, 2026: Short sales 45.3%
- Oct 14, 2026: Short sales 42.8%
- Oct 15, 2026: Short sales 35.2%
- Oct 16, 2026: Short sales 55.7%
- Oct 19, 2026: Short sales 55.1%
- Oct 20, 2026: Short sales 65%
- Oct 21, 2026: Short sales 48%
- Oct 22, 2026: Short sales 59.5%
- Oct 23, 2026: Short sales 48.7%
- Oct 26, 2026: Short sales 50.7%
- Oct 27, 2026: Short sales 36.9%
- Oct 28, 2026: Short sales 49.8%
- Oct 29, 2026: Short sales 42.2%
- Oct 30, 2026: Short sales 44.2%
- Nov 2, 2026: Short sales 40%
- Nov 3, 2026: Short sales 51.2%
- Nov 4, 2026: Short sales 35.4%
- Nov 5, 2026: Short sales 44.3%
- Nov 6, 2026: Short sales 38.9%
- Nov 9, 2026: Short sales 39.6%
- Nov 10, 2026: Short sales 43.3%
- Nov 11, 2026: Short sales 48%
- Nov 12, 2026: Short sales 56.9%
- Nov 13, 2026: Short sales 45.5%
- Nov 16, 2026: Short sales 45.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Frederic H MollDirectorDirectly866.5K
- Kevin WatersEVP, CFODirectly180.4K
- Reza ZadnoPresident, CEODirectly173.1K
- Alaleh NouriEVP, CLO, CORP. SEC.Directly127.7K
- Pooja SharmaChief Strat/Marketing OfficerDirectly106.5K
- Taylor C. HarrisDirectorDirectly102.5K
- Barry L TemplinEVP, Chief Technology OfficerDirectly94.8K
- Hisham ShiblaqEVP, Chief Comm. OfficerDirectly70.8K
- Thomas M KrummelDirectorDirectly45.6K
- Antal Rohit DesaiDirectorDirectly38.5K
- Larry L WoodPresident, CEODirectly–
- Mary GarrettDirectorDirectly17.7K
- Elisabeth Sandoval LittleDirectorDirectly15.9K
- Amy M. DodrillDirectorDirectly10.9K
- Dan PuckettDirectorDirectly8,791
- Michael MackDirectorDirectly7,727
- Thomas M PrescottDirectorDirectly7,211
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Frederic H MollDirector | 866.5K | – | Jun 9, 2026 | Form 4 |
| Kevin WatersEVP, CFO | 180.4K | – | Sep 9, 2026 | Form 4 |
| Reza ZadnoPresident, CEO | 173.1K | – | Mar 18, 2025 | Form 4 |
| Alaleh NouriEVP, CLO, CORP. SEC. | 127.7K | – | Sep 9, 2026 | Form 4 |
| Pooja SharmaChief Strat/Marketing Officer | 106.5K | – | Nov 6, 2026 | Form 4 |
| Taylor C. HarrisDirector | 102.5K | – | Jun 9, 2026 | Form 4 |
| Barry L TemplinEVP, Chief Technology Officer | 94.8K | – | Sep 9, 2026 | Form 4 |
| Hisham ShiblaqEVP, Chief Comm. Officer | 70.8K | – | Jun 6, 2025 | Form 4 |
| Thomas M KrummelDirector | 45.6K | – | May 1, 2024 | Form 4 |
| Antal Rohit DesaiDirector | 38.5K | – | Jun 9, 2026 | Form 4 |
| Larry L WoodPresident, CEO | – | 23.9K | Aug 7, 2026 | Form 4 |
| Mary GarrettDirector | 17.7K | – | Jun 9, 2026 | Form 4 |
| Elisabeth Sandoval LittleDirector | 15.9K | – | Jun 9, 2026 | Form 4 |
| Amy M. DodrillDirector | 10.9K | – | Jun 9, 2026 | Form 4 |
| Dan PuckettDirector | 8,791 | – | Jun 9, 2026 | Form 4 |
| Michael MackDirector | 7,727 | – | Oct 2, 2026 | Form 4 |
| Thomas M PrescottDirector | 7,211 | – | Jun 9, 2026 | Form 4 |
A lower bound: it counts only the 17 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHIiShares U.S. Medical Devices ETFWeight in the fund0.20%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.08%
- IWMiShares Russell 2000 ETFWeight in the fund0.04%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.04%
- VBKVanguard Small-Cap Growth Index FundWeight in the fund0.03%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.03%
- VHTVanguard Health Care Index FundWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
- VBVanguard Small-Cap Index FundWeight in the fund0.01%
- ONEQFidelity Nasdaq Composite Index ETFWeight in the fund0.00%
15 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 242
- Q4 2025: Managers 263
- Q1 2026: Managers 260
- Q2 2026: Managers 254
Institutional investors by quarter
The fund managers holding PRCT, quarter by quarter, from Q3 2021 to Q2 2025, 16 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 254 managers held 54.86M shares, worth $1.2B. During the quarter 38 opened a position, 44 closed one, 106 added and 65 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+12%
- T. Rowe Price Investment ManagementIn the quarter-0.2%
- BNP PARIBAS ASSET MANAGEMENT HoldingIn the quarter-8.6%
- Vanguard Portfolio ManagementIn the quarter+4.4%
- Vanguard Capital ManagementIn the quarter+2.6%
- Chicago CapitalIn the quarter-4.0%
- State StreetIn the quarter+5.7%
- Geode Capital ManagementIn the quarter+8.8%
- FMRIn the quarter-1.2%
- Price T Rowe AssociatesIn the quarter+120%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 4.87M | +12% | $110M |
| T. Rowe Price Investment Management | 3.27M | -0.2% | $74M |
| BNP PARIBAS ASSET MANAGEMENT Holding | 2.82M | -8.6% | $64M |
| Vanguard Portfolio Management | 2.53M | +4.4% | $57M |
| Vanguard Capital Management | 2.46M | +2.6% | $56M |
| Chicago Capital | 2.07M | -4.0% | $47M |
| State Street | 1.62M | +5.7% | $37M |
| Geode Capital Management | 1.48M | +8.8% | $34M |
| FMR | 1.44M | -1.2% | $33M |
| Price T Rowe Associates | 1.33M | +120% | $30M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do PROCEPT BioRobotics's filings show?
Who buys and sells is one part of PROCEPT BioRobotics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have PRCT's insiders bought or sold?
From Jun 10, 2026 to Nov 6, 2026 PROCEPT BioRobotics's insiders bought $498.3K and sold $143.2K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold PRCT?
4 of the managers we track held the shares on Jun 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $14M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.